首页 | 本学科首页   官方微博 | 高级检索  
检索        

皮肤病中c-Jun氨基末端蛋白激酶通路的研究现况
引用本文:任重庆,廖文俊.皮肤病中c-Jun氨基末端蛋白激酶通路的研究现况[J].国际皮肤性病学杂志,2016(2):110-113.
作者姓名:任重庆  廖文俊
作者单位:第四军医大学西京皮肤医院, 西安,710032
基金项目:国家自然科学基金(81072235),National Natural Science Foundation of China(81072235)
摘    要:c-Jun氨基末端蛋白激酶是丝裂原活化蛋白激酶家族的成员,调节细胞的生长、发育、增殖和分化.c-Jun氨基末端蛋白激酶的异常表达与人皮肤疾病的发生、发展密切相关.研究证实,c-Jun氨基末端蛋白激酶在多种皮肤疾病患者的真/表皮中表达过度增高及异常活化,进而导致细胞的生长、发育、增殖、分化异常以及炎症反应和细胞凋亡的发生.选择阻断c-Jun氨基末端蛋白激酶通路的异常活化可以使病情得到改善.针对c-Jun氨基末端蛋白激酶信号通路的靶向治疗已经成为目前多种皮肤病的研究热点.

关 键 词:皮肤疾病  MAP激酶信号系统  信号传导  黑色素瘤  JNK丝裂原活化蛋白激酶类

c-Jun N-terminal kinase signaling pathway in skin diseases
Abstract:The c-Jun N-terminal kinase (JNK) is a member of the mitogen-activated protein kinase (MAPK) family,and can regulate cell growth,development,proliferation and differentiation.Aberrant expression of JNK is closely associated with occurrence and development of human skin diseases.Studies have confirmed that JNK is overexpressed and abnormally activated in the dermis/epidermis of patients with various skin diseases,which can cause abnormalities in cell growth,development,proliferation and differentiation,as well as occurrence of inflammation and apoptosis.Selective blocking of aberrant activation of the JNK signaling pathway may improve patients' condition.At present,therapies targeting the JNK signaling pathway have become a research hotspot in various skin diseases.
Keywords:Skin diseases  MAP kinase signaling system  Signal transduction  Melanoma  JNK mitogen-activated protein kinases
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号